mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.02 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |